**Core Concept**
The question is testing knowledge of the clinical presentation of metastatic cancer in the neck. Metastatic cancer in the neck can arise from various primary sites, and the frequency of palpable metastasis can vary depending on the primary site. The neck is a common site for metastasis from head and neck cancers, particularly squamous cell carcinoma of the oral cavity, oropharynx, and larynx.

**Why the Correct Answer is Right**
The highest frequency of palpable metastasis in the neck is seen in lymph nodes involved in the metastasis of squamous cell carcinoma of the oral cavity. The metastasis to the neck is usually through the lymphatic spread, and the most common site of metastasis is the jugulodigastric lymph node. This is because the jugulodigastric lymph node is a key lymph node in the neck that receives lymphatic drainage from the oral cavity, oropharynx, and larynx. The metastasis to these lymph nodes can lead to the formation of palpable lymphadenopathy, which is a common presenting feature of metastatic cancer in the neck.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because while metastasis to the neck can occur from other primary sites, such as breast cancer, the frequency is lower compared to squamous cell carcinoma of the oral cavity.
* **Option B:** This option is incorrect because while thyroid cancer can metastasize to the neck, the frequency of palpable metastasis is lower compared to squamous cell carcinoma of the oral cavity.
* **Option C:** This option is incorrect because while lung cancer can metastasize to the neck, the frequency of palpable metastasis is lower compared to squamous cell carcinoma of the oral cavity.

**Clinical Pearl / High-Yield Fact**
When evaluating a patient with a palpable mass in the neck, it is essential to consider the possibility of metastatic cancer, particularly from the head and neck region. A thorough history and physical examination, including a detailed neck examination, can help identify the primary site of the cancer and guide further management.

**Correct Answer:** B.